For everyone that does not know, here is the 13D umbass
For everyone that does not know, here is the 13D umbass plan...
Get enough gullible longs to hand us their votes by throwing shit everywhere and getting some to stick
Put all of our 60,000,000 shares in margin accounts so our Big pharma funded shortseller friends have ammunition to stop upward momentum in the share price and to make longs question why their investment looks bad on paper which helps to water the seeds of doubt we are planting on message boards (flat out lies) about current management
Get those gullible longs to vote with us and see if we have enough to take over the company withought having to buy more shares which would drive up the price
If we do get enough votes (no way in hell this will happen) take over management, then dilute the shares and use the money raised to buy inceldx for waaaay more than it is worth
next sell CYDY at a bargain basement price to the large pharmaceutical that has been funding the short sellers, false lawsuits and hit pieces against Nader and CYDY and has promised us cushy jobs and golden parachutes
next get compensated by this big pharmaceutical for a job 'well done' in various forms.
Big Pharma places Leronlimab back on a shelf where it goes back to collecting dust
And finally, in December, send a nice Christmas or Hannukah card from a tropical island we bought with all the $$$ we made to the stupid gullible longs that handed us over the votes we needed to fck them outta getting their own island
THE END
36
1
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...
Continue Reading
Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...
Continue Reading
NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...
Continue Reading
Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...
Continue Reading
Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...
Continue Reading
A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...
Continue Reading
China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...
Continue Reading
A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...
Continue Reading
Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...
Continue Reading
Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...
Continue Reading
Top 5 Most Recently Viewed Articles
Revolutionary Check Printing Solutions for Businesses In today's fast-paced business environment, efficient solutions are essential. One innovative tool that has emerged is the ezCheckPrinting software, combined with a virtual printer, designed specifically for QuickBooks and Quicken users. This powerful combination facilitates unlimited check printing directly onto blank...
Continue Reading
Kelso Technologies' Strategic Outlook for 2025 Kelso Technologies Inc (TSX: KLS) has outlined its ambitious goals for 2025 amid a recovering economy. The Board of Directors has given the green light to a budget that anticipates a sales growth margin between 0% to 5% compared to the previous fiscal year. The company expects revenues for fiscal year 2024 to reach...
Continue Reading
Revelation Biosciences Launches PRIME Phase 1b Clinical Study Revelation Biosciences, Inc. is embarking on an exciting chapter as it announces the initiation of its PRIME Phase 1b clinical study aimed at examining the effects of Gemini, a proprietary formulation designed to assist in the treatment of Chronic Kidney Disease (CKD). The company, focused on leveraging the...
Continue Reading
Overview of Treasury Bills Auction Results The auction for treasury bills held on a recent date revealed important data regarding bids, sales, and prices. Investors and market analysts keep a close eye on these outcomes to gauge market conditions and make informed decisions. Detailed Auction Data The following section provides comprehensive details on the bids, sale...
Continue Reading
Rare Earths and Rate Talks Steal the Spotlight You ever feel like every time you look at the market, something’s ready to pop or drop? Today’s no exception, with IMC Rare Earths making its grand debut while everyone's ears are peeled for the Fed. Now, a fresh pair of dice are rolling on Wall Street, as IMC steps onto the NYSE American. Breaking Down the IMC IPO This...
Continue Reading